---
title: "This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286776550.md"
description: "Wall Street analysts have downgraded several stocks, including Applied Materials (AMAT) from Overweight to Equal-Weight with a $502 price target. Other downgrades include Outlook Therapeutics (OTLK), CoreWeave (CRWV), Regeneron Pharmaceuticals (REGN), and LiveRamp Holdings (RAMP). For a complete list of analyst rating changes, visit Benzinga's analyst ratings page."
datetime: "2026-05-18T12:53:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286776550.md)
  - [en](https://longbridge.com/en/news/286776550.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286776550.md)
---

# This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BTIG analyst Julian Harrison downgraded **Outlook Therapeutics Inc** (NASDAQ:OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.
-   Morgan Stanley analyst Shane Brett downgraded **Applied Materials Inc** (NASDAQ:AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how other analysts view this stock.
-   DA Davidson analyst Gil Luria downgraded **CoreWeave Inc** (NASDAQ:CRWV) from Buy to Neutral and cut the price target from $175 to $100. CoreWeave shares closed at $107.30 on Friday. See how other analysts view this stock.
-   Leerink Partners analyst Andrew Berens downgraded **Regeneron Pharmaceuticals Inc** (NASDAQ:REGN) from Outperform to Market Perform and slashed the price target from $792 to $641. Regeneron Pharmaceuticals shares closed at $698.25 on Friday. See how other analysts view this stock.
-   DA Davidson analyst Clark Wright downgraded **LiveRamp Holdings** (NYSE:RAMP) from Buy to Neutral and raised the price target from $35 to $38.5. LiveRamp shares closed at $29.66 on Friday. See how other analysts view this stock.

Considering buying CRWV stock? Here’s what analysts think:

Photo via Shutterstock

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [RAMP.US](https://longbridge.com/en/quote/RAMP.US.md)
- [CRWV.US](https://longbridge.com/en/quote/CRWV.US.md)
- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [PSI.US](https://longbridge.com/en/quote/PSI.US.md)
- [SMH.US](https://longbridge.com/en/quote/SMH.US.md)
- [XSD.US](https://longbridge.com/en/quote/XSD.US.md)
- [AMAT.US](https://longbridge.com/en/quote/AMAT.US.md)

## Related News & Research

- [Why LiveRamp stock soared today](https://longbridge.com/en/news/286831295.md)
- [Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.](https://longbridge.com/en/news/286811938.md)
- [Publicis Makes AI Data Play With LiveRamp Acquisition](https://longbridge.com/en/news/286768409.md)
- [Publicis Groupe expands AI ambitions with $2.2B LiveRamp buyout](https://longbridge.com/en/news/286689759.md)
- [France's Publicis to buy US data firm LiveRamp in $2.2 billion](https://longbridge.com/en/news/286678167.md)